Cara Therapeutics, Inc. Quarterly Income Tax Expense (Benefit) in USD from Q1 2013 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Cara Therapeutics, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q1 2013 to Q3 2024.
  • Cara Therapeutics, Inc. Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was $0.000.
  • Cara Therapeutics, Inc. Income Tax Expense (Benefit) for the twelve months ending September 30, 2024 was $0.000.
  • Cara Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2023 was $0.000.
  • Cara Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2022 was $0.000.
  • Cara Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2021 was $0.000.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $0 $0 $0 Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-14
Q2 2024 $0 $0 $0 Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 $0 $0 $0 Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-13
Q4 2023 $0 $0 $0 Oct 1, 2023 Dec 31, 2023 10-K 2024-03-06
Q3 2023 $0 $0 $0 Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 $0 $0 $0 Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 $0 $0 $0 Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-13
Q4 2022 $0 $0 $0 Oct 1, 2022 Dec 31, 2022 10-K 2024-03-06
Q3 2022 $0 $0 $0 Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 $0 $0 $0 Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-07
Q1 2022 $0 $0 $0 Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 $0 $0 +$255K Oct 1, 2021 Dec 31, 2021 10-K 2024-03-06
Q3 2021 -$255K $0 +$132K Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-07
Q2 2021 -$387K $0 +$182K Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 -$569K $0 +$122K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q4 2020 -$691K -$255K -$89K -53.6% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-06
Q3 2020 -$602K -$132K +$198K +60% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-08
Q2 2020 -$800K -$182K +$53K +22.6% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 -$853K -$122K -$37K -43.5% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-10
Q4 2019 -$816K -$166K -$41K -32.8% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-01
Q3 2019 -$775K -$330K -$264K -400% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 -$511K -$235K -$83K -54.6% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 -$428K -$85K -$39K -84.8% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q4 2018 -$389K -$125K -$99K -381% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-25
Q3 2018 -$290K -$66K +$79K +54.5% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-05
Q2 2018 -$369K -$152K -$150K -7500% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-07
Q1 2018 -$219K -$46K -$15K -48.4% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-07
Q4 2017 -$204K -$26K +$163K +86.2% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-27
Q3 2017 -$367K -$145K -$90K -164% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-06
Q2 2017 -$277K -$2K +$77K +97.5% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-07
Q1 2017 -$354K -$31K +$114K +78.6% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-09
Q4 2016 -$468K -$189K -$42K -28.6% Oct 1, 2016 Dec 31, 2016 10-K 2019-03-12
Q3 2016 -$426K -$55K +$145K +72.5% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-02
Q2 2016 -$571K -$79K -$44K -126% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-03
Q1 2016 -$527K -$145K -$130K -867% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-04
Q4 2015 -$397K -$147K -$5K -3.52% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-15
Q3 2015 -$392K -$200K -$168K -525% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-04
Q2 2015 -$224K -$35K -$24K -218% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-04
Q1 2015 -$200K -$15K +$1K +6.25% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-05
Q4 2014 -$201K -$142K -$139K -4633% Oct 1, 2014 Dec 31, 2014 10-K 2017-03-10
Q3 2014 -$62K -$32K -$32K Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-09
Q2 2014 -$30K -$11K +$9K +45% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-10
Q1 2014 -$39K -$16K -$9K -129% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-12
Q4 2013 -$30K -$3K Oct 1, 2013 Dec 31, 2013 10-K 2016-03-11
Q3 2013 $0 Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-10
Q2 2013 -$20K Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-07
Q1 2013 -$7K Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.